ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 183K)  | Related Articles | Citation Tracking

Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori
T. Breuer 1 , J. G. Kim 2 , I. E. Gurer 1 , D. P. Graham 1 , M. Osato 1 , R. M. Genta 1, 3 & D. Y. Graham 1, 4
  1 Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA,   2 Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea,   3 Department of Pathology, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA,   4 Division of Molecular Virology, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
Correspondence to D. Y. Graham, Veterans Affairs Medical Center (111D), Rm 3A352, 2002 Holcombe Blvd., Houston, Texas 77030, USA.
Copyright 1997 Blackwell Science Ltd.

ABSTRACT

 

Aim:

Effective anti-Helicobacter pylori therapies with few side-effects are needed. We studied the effectiveness of a low-dose combination of metronidazole, amoxycillin and omeprazole for treatment of ulcer patients in Seoul, Korea.

 

Methods:

Patients with gastric or duodenal ulcer received metronidazole (125 mg b.d.), amoxycillin (500 mg b.d.) and omeprazole (20 mg at bedtime) for 2 weeks. Endoscopic examinations were performed before treatment and at least 6 weeks after completion of antimicrobial therapy. H. pylori status was confirmed by histological examination of two gastric biopsies using the Genta stain.

 

Results:

Seventy-nine patients (64 men, 15 women, mean age 46 years) with peptic ulcer were enrolled. H. pylori infection was cured in 56 (71%, 95% CI: 60–81%). The cure rate in non-smokers was significantly higher than in smokers (88% vs. 65%, P=0.035). Twelve pre-treatment isolates were available and metronidazole resistance was noted in all; H. pylori infection was cured in 10. Thirty-six patients cured of H. pylori have been followed for 1 year (mean of 361 days) and 2 cases became reinfected (5.5%, 95% CI: 1–18%).

 

Conclusions:

The low-dose combination of metronidazole, amoxycillin and omeprazole was effective even in the face of metronidazole resistance. Recurrence of H. pylori infection is infrequent even in countries with a high prevalence of H. pylori infection.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1365-2036.1997.00173.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Click here
Sign Up Now
Wiley Medical Twitter